Nicotinic Antagonists
DBCAT000919Pharmacologic class
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system... A DrugBank category of 50 drugs. 38 of them are approved.
- Part of
- Anticholinergic Agents
- Also known as
- Antagonists, Nicotinic · Antinicotinic agents · Nicotinic-Antagonists
- Drugs
- Agmatine
- Alcuronium
- Amantadine
- Amobarbital
- Aprobarbital
- Atracurium
- Atracurium besylate
- Barbital
- Biperiden
- Butabarbital
- Butalbital
- Butobarbital
- Chlorisondamine
- Cisatracurium
- Dextromethorphan
- Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
- Doxacurium
- Fluoxetine
- Gallamine
- Gallamine triethiodide
- Gantacurium
- Heptabarbital
- Hexafluronium
- Hexamethonium
- Hexobarbital
What you can answer from here — as of July 09, 2019
Which targets do Nicotinic Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account